Literature DB >> 9585482

Selective protein adduct formation of diclofenac glucuronide is critically dependent on the rat canalicular conjugate export pump (Mrp2).

S Seitz1, A Kretz-Rommel, R P Oude Elferink, U A Boelsterli.   

Abstract

Previous work demonstrates that the reactive acyl glucuronide of the nonsteroidal antiinflammatory drug diclofenac forms selective protein adducts in the liver, which may play a causal role in the pathogenesis of diclofenac-associated liver toxicity. Because glucuronide conjugates can be exported into the bile, we explored the role of diclofenac glucuronide hepatobiliary transport in the formation of site-specific protein adducts. Specifically, to analyze intracellular (hepatocytes) versus extracellular (biliary tree) targeting of proteins, we have compared the pattern of diclofenac binding in normal Wistar rats with that in mutant transport-deficient (TR-) rats which lack the functional canalicular isoform of the conjugate export pump, Mrp2. In bile duct-cannulated normal rats, >50% of an iv injected dose of [14C]diclofenac appeared in the bile over a 90-min period. In contrast, in TR- rats virtually no hepatobiliary excretion of diclofenac glucuronide was found. After administration of diclofenac (30 mg/kg/day, ip for 3 days) to rats of both genotypes, a major protein adduct of an apparent molecular mass of 118 kDa was selectively detected by immunoblotting in isolated canalicular, but not in basolateral, membrane subfractions of wild-type rats, whereas no plasma membrane adducts could be found in the livers of TR- rats. Furthermore, immunohistochemical analysis using an anti-diclofenac antibody revealed the presence of distinct diclofenac-modified proteins on canalicular membranes of liver sections from diclofenac-treated normal rats, whereas no adducts could be identified in livers of TR- rats. In Western blots, the major diclofenac-modified canalicular membrane protein did not comigrate with Mrp2, indicating that the glucuronide carrier itself was unlikely to be a target. Collectively, the results demonstrate that the reactive diclofenac glucuronide is selectively transported into bile via Mrp2 and that hepatobiliary transport is critical for diclofenac covalent binding to proteins in the biliary tree.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9585482     DOI: 10.1021/tx970203+

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  14 in total

1.  Active site flexibility revealed in crystal structures of Parabacteroides merdae β-glucuronidase from the human gut microbiome.

Authors:  Michael S Little; Samantha M Ervin; William G Walton; Ashutosh Tripathy; Yongmei Xu; Jian Liu; Matthew R Redinbo
Journal:  Protein Sci       Date:  2018-10-27       Impact factor: 6.725

Review 2.  A perspective on efflux transport proteins in the liver.

Authors:  K Köck; K L R Brouwer
Journal:  Clin Pharmacol Ther       Date:  2012-09-05       Impact factor: 6.875

3.  Multidrug Resistance-Associated Protein 3 Plays an Important Role in Protection against Acute Toxicity of Diclofenac.

Authors:  Renato J Scialis; Iván L Csanaky; Michael J Goedken; José E Manautou
Journal:  Drug Metab Dispos       Date:  2015-04-20       Impact factor: 3.922

4.  Elucidation of the Mechanisms through Which the Reactive Metabolite Diclofenac Acyl Glucuronide Can Mediate Toxicity.

Authors:  Renato J Scialis; José E Manautou
Journal:  J Pharmacol Exp Ther       Date:  2016-02-11       Impact factor: 4.030

5.  Bacterial β-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: mode of action and pharmacokinetics.

Authors:  Kyle S Saitta; Carmen Zhang; Kang Kwang Lee; Kazunori Fujimoto; Matthew R Redinbo; Urs A Boelsterli
Journal:  Xenobiotica       Date:  2013-07-05       Impact factor: 1.908

6.  Identification and Characterization of Efflux Transporters That Modulate the Subtoxic Disposition of Diclofenac and Its Metabolites.

Authors:  Renato J Scialis; Lauren M Aleksunes; Iván L Csanaky; Curtis D Klaassen; José E Manautou
Journal:  Drug Metab Dispos       Date:  2019-08-09       Impact factor: 3.922

7.  Rofecoxib-induced hepatotoxicity: a forgotten complication of the coxibs.

Authors:  Brian Yan; Yvette Leung; Stefan J Urbanski; Robert P Myers
Journal:  Can J Gastroenterol       Date:  2006-05       Impact factor: 3.522

8.  Glucuronidation and covalent protein binding of benoxaprofen and flunoxaprofen in sandwich-cultured rat and human hepatocytes.

Authors:  Jennifer Q Dong; Philip C Smith
Journal:  Drug Metab Dispos       Date:  2009-09-22       Impact factor: 3.922

Review 9.  Mechanisms of NSAID-induced hepatotoxicity: focus on nimesulide.

Authors:  Urs A Boelsterli
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 10.  Inflammatory stress and idiosyncratic hepatotoxicity: hints from animal models.

Authors:  Xiaomin Deng; James P Luyendyk; Patricia E Ganey; Robert A Roth
Journal:  Pharmacol Rev       Date:  2009-09       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.